Matthewman Cristina, Narin Alexandra, Huston Hannah, Hopkins Christopher Edward
Life Extension, Fort Lauderdale, Florida, 33309, USA.
InVivo Biosystems, Eugene, OR, 97402, USA.
Mol Aspects Med. 2023 Jun;91:101115. doi: 10.1016/j.mam.2022.101115. Epub 2022 Sep 11.
The human gut microbiome is a complex and dynamic microbial entity that interacts with the environment and other parts of the body including the brain, heart, liver, and immune system. These multisystem interactions are highly conserved from invertebrates to humans, however the complexity and diversity of human microbiota compositions often yield a context that is unique to each individual. Yet commonalities remain across species, where a healthy gut microbiome will be rich in symbiotic commensal biota while an unhealthy gut microbiota will be experiencing abnormal blooms of pathobiont bacteria. In this review we discuss how omics technologies can be applied in a personalized approach to understand the microbial crosstalk and microbial-host interactions that affect the delicate balance between eubiosis and dysbiosis in an individual gut microbiome. We further highlight the strengths of model organisms in identifying and characterizing these conserved synergistic and/or pathogenic host-microbe interactions. And finally, we touch upon the growing area of personalized therapeutic interventions targeting gut microbiome.
人类肠道微生物群是一个复杂且动态的微生物实体,它与环境以及身体的其他部位相互作用,包括大脑、心脏、肝脏和免疫系统。这些多系统相互作用从无脊椎动物到人类都高度保守,然而人类微生物群组成的复杂性和多样性往往产生每个个体独有的情况。然而,不同物种之间仍存在共性,健康的肠道微生物群富含共生的有益生物群落,而不健康的肠道微生物群则会出现致病共生菌的异常繁殖。在这篇综述中,我们讨论了组学技术如何以个性化的方式应用,以理解影响个体肠道微生物群中有益菌和有害菌之间微妙平衡的微生物相互作用以及微生物与宿主的相互作用。我们进一步强调了模式生物在识别和表征这些保守的协同和/或致病宿主-微生物相互作用方面的优势。最后,我们提及了针对肠道微生物群的个性化治疗干预这一不断发展的领域。